Terkko Navigator / Experimental Hematology & Oncology

AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL

Targeting phosphoglycerate dehydrogenase in multiple myeloma

The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

CD44 as a tumor biomarker and therapeutic target

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation

Engineering better chimeric antigen receptor T cells

Recent updates for antibody therapy for acute lymphoblastic leukemia

Complex roles of cAMP–PKA–CREB signaling in cancer

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia

Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma

Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma

The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of thera

miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR

Frontiers in the COVID-19 vaccines development

Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

Risk factors and outcome of COVID-19 in patients with hematological malignancies

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients

Macrophage, the potential key mediator in CAR-T related CRS